E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 16566971)

Published in Urology on March 29, 2006

Authors

Rodrigo Sousa Madeira Campos1, Ademar Lopes, Gustavo Cardoso Guimarães, André Lopes Carvalho, Fernando Augusto Soares

Author Affiliations

1: Department of Pelvic Surgery, Centro de Tratamento e Pesquisa Hospital do Câncer A.C. Camargo, São Paulo, Brazil.

Articles by these authors

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett (2006) 2.37

The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79

Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer. J Mol Med (Berl) (2006) 1.72

Pectoralis major and other myofascial/myocutaneous flaps in head and neck cancer reconstruction: experience with 437 cases at a single institution. Head Neck (2004) 1.66

Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution. J Surg Oncol (2006) 1.55

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res (2005) 1.46

Can a sentinel node mapping algorithm detect all positive lymph nodes in cervical cancer? Ann Surg Oncol (2014) 1.45

Pelvic exenteration and sphincter preservation: an analysis of 96 cases. J Surg Oncol (2004) 1.44

Detection of micrometastases in pN0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry. J Bras Pneumol (2008) 1.41

GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules (2010) 1.27

Computed tomography guided needle biopsy: experience from 1,300 procedures. Sao Paulo Med J (2006) 1.23

Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas. Oral Oncol (2003) 1.21

Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol (2004) 1.20

Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int J Cancer (2009) 1.19

Colorectal cancer "methylator phenotype": fact or artifact? Neoplasia (2005) 1.13

Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol (2009) 1.12

Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncol Rep (2010) 1.11

Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol (2007) 1.11

Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck. Oral Oncol (2004) 1.09

Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch (2008) 1.01

Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer. Int J Oncol (2010) 1.00

Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). J Bioenerg Biomembr (2012) 1.00

Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS One (2013) 0.99

ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery. Int J Colorectal Dis (2009) 0.99

HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer (2012) 0.99

Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma. Oral Oncol (2005) 0.98

Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas. Clinics (Sao Paulo) (2012) 0.98

Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck (2006) 0.97

Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer. J Clin Endocrinol Metab (2010) 0.97

Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors. Transl Oncol (2010) 0.97

High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97

A school-based human papillomavirus vaccination program in barretos, Brazil: final results of a demonstrative study. PLoS One (2013) 0.97

Primary oral mucosal melanoma: a series of 35 new cases from South America. Am J Dermatopathol (2009) 0.97

Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol (2009) 0.97

Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocr Relat Cancer (2013) 0.96

Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys (2005) 0.96

Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer (2004) 0.95

Hearing loss and complaint in patients with head and neck cancer treated with radiotherapy. Arch Otolaryngol Head Neck Surg (2010) 0.95

Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann Surg Oncol (2002) 0.94

Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome. Hum Pathol (2013) 0.94

Expression of cancer/testis antigens is correlated with improved survival in glioblastoma. Oncotarget (2013) 0.94

Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands. Oral Oncol (2005) 0.93

Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck. Arch Otolaryngol Head Neck Surg (2003) 0.93

Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol (2006) 0.93

Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol (2011) 0.93

Sex with animals (SWA): behavioral characteristics and possible association with penile cancer. A multicenter study. J Sex Med (2011) 0.93

Surgical treatment of paragangliomas of the carotid bifurcation: results of 36 patients. Head Neck (2004) 0.92

High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer (2011) 0.92

CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck (2011) 0.92

TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors. J Transl Med (2013) 0.92

Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg (2008) 0.92

Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer. J Transl Med (2013) 0.92

Cytokeratin-based CTC counting unrelated to clinical follow up. J Thorac Dis (2013) 0.91

Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastases. Urology (2006) 0.90

Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg (2004) 0.90

Prognostication of OCT4 isoform expression in prostate cancer. Tumour Biol (2013) 0.90

Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer. BMC Cancer (2013) 0.90

Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients. Arch Otolaryngol Head Neck Surg (2008) 0.89

Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical. Pathol Oncol Res (2008) 0.89

In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas. Transl Oncol (2013) 0.89

Identification of upregulated genes in oral squamous cell carcinomas. Head Neck (2012) 0.89

Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk. Clinics (Sao Paulo) (2011) 0.89

Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma. Histopathology (2011) 0.89

Penile metastasis of chondrosarcoma of the jaw. Urology (2003) 0.89

Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope (2007) 0.88

Developing human minor salivary glands: morphological parallel relation between the expression of TGF-beta isoforms and cytoskeletal markers of glandular maturation. Virchows Arch (2007) 0.88

TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer (2013) 0.88

The interference of cold ischemia time in the quality of total RNA from frozen tumor samples. Cell Tissue Bank (2012) 0.88

SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis. Cancer Lett (2009) 0.87

Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports. Int J Colorectal Dis (2011) 0.87

Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg (2008) 0.87

Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer. Genet Mol Res (2006) 0.87

Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. Gastric Cancer (2008) 0.87

[Immunophenotype and evolution of breast carcinomas: a comparison between very young and postmenopausal women]. Rev Bras Ginecol Obstet (2009) 0.87

Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma. Oral Oncol (2010) 0.87

Clinical utility of KAP-1 expression in thyroid lesions. Endocr Pathol (2013) 0.87

Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate. Urol Int (2007) 0.86

Absence of TGF-βRII predicts bone and lung metastasis and is associated with poor prognosis in stage III breast tumors. Cancer Biomark (2012) 0.86

Synchronous ameloblastoma and orthokeratinized odontogenic cyst of the mandible. J Oral Pathol Med (2006) 0.86

Caspase expression in oral squamous cell carcinoma. Head Neck (2010) 0.86

Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma. J Surg Oncol (2012) 0.85

Upstaging benefits and accuracy of sentinel lymph node mapping in colorectal adenocarcinoma nodal staging. J Surg Oncol (2008) 0.85

Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer. Endocr Relat Cancer (2012) 0.85

Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study. Hum Pathol (2011) 0.85

Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors. Tumour Biol (2011) 0.85